OBALON THERPTCS (OBLN)
(Delayed Data from NSDQ)
$0.43 USD
-0.01 (-3.15%)
Updated May 3, 2019 03:59 PM ET
After-Market: $0.43 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
ReShape Lifesciences Inc. [OBLN]
Reports for Purchase
Showing records 1 - 20 ( 27 total )
Company: ReShape Lifesciences Inc.
Industry: Medical - Instruments
Company: ReShape Lifesciences Inc.
Industry: Medical - Instruments
Company: ReShape Lifesciences Inc.
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: ReShape Lifesciences Inc.
Industry: Medical - Instruments
Company: ReShape Lifesciences Inc.
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: ReShape Lifesciences Inc.
Industry: Medical - Instruments
4Q18 Recap - Neutral Pending Signs of Significant Traction
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: ReShape Lifesciences Inc.
Industry: Medical - Instruments
We are transferring lead coverage to Scott Henry due to the departure of the covering analyst
Provider: Roth Capital Partners, Inc.
Company: ReShape Lifesciences Inc.
Industry: Medical - Instruments
We are transferring coverage, placing Under Review, and removing PT''s and estimates
Provider: Roth Capital Partners, Inc.
Company: ReShape Lifesciences Inc.
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: ReShape Lifesciences Inc.
Industry: Medical - Instruments
Company: ReShape Lifesciences Inc.
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: ReShape Lifesciences Inc.
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: ReShape Lifesciences Inc.
Industry: Medical - Instruments
Company: ReShape Lifesciences Inc.
Industry: Medical - Instruments
Company: ReShape Lifesciences Inc.
Industry: Medical - Instruments
Healthcare - Medical Technology: Key Takeaways From Obesity Week on U.S. Balloon Market
Provider: Roth Capital Partners, Inc.
Analyst: SOLOMON D
Company: ReShape Lifesciences Inc.
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: ReShape Lifesciences Inc.
Industry: Medical - Instruments
Clinical Data Validates Obalon''s Safety, Tolerability - Efficacy
Provider: Roth Capital Partners, Inc.
Analyst: SOLOMON D
Company: ReShape Lifesciences Inc.
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: ReShape Lifesciences Inc.
Industry: Medical - Instruments
Company: ReShape Lifesciences Inc.
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.